Aurisco Pharmaceutical Co Ltd
SSE:605116
| US |
|
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
| US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Mastercard Inc
NYSE:MA
|
Technology
|
| US |
|
Abbvie Inc
NYSE:ABBV
|
Biotechnology
|
| US |
|
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
|
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
| US |
|
Visa Inc
NYSE:V
|
Technology
|
| CN |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
| US |
|
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
| US |
|
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
| US |
|
Coca-Cola Co
NYSE:KO
|
Beverages
|
| US |
|
Realty Income Corp
NYSE:O
|
Real Estate
|
| US |
|
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
| US |
|
Walt Disney Co
NYSE:DIS
|
Media
|
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
This note will be permanently deleted.
Aurisco Pharmaceutical Co Ltd
Free Cash Flow
Aurisco Pharmaceutical Co Ltd
Free Cash Flow Peer Comparison
600436
600276
000538
Competitive Free Cash Flow Analysis
Latest Figures & CAGR of Competitors
| Company | Free Cash Flow | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
A
|
Aurisco Pharmaceutical Co Ltd
SSE:605116
|
Free Cash Flow
¥80.1m
|
CAGR 3-Years
13%
|
CAGR 5-Years
39%
|
CAGR 10-Years
N/A
|
|
H
|
Hansoh Pharmaceutical Group Company Ltd
HKEX:3692
|
Free Cash Flow
¥2.9B
|
CAGR 3-Years
44%
|
CAGR 5-Years
11%
|
CAGR 10-Years
N/A
|
|
|
Zhangzhou Pientzehuang Pharmaceutical Co Ltd
SSE:600436
|
Free Cash Flow
¥2B
|
CAGR 3-Years
11%
|
CAGR 5-Years
20%
|
CAGR 10-Years
28%
|
|
|
Jiangsu Hengrui Pharmaceuticals Co Ltd
SSE:600276
|
Free Cash Flow
¥7B
|
CAGR 3-Years
76%
|
CAGR 5-Years
25%
|
CAGR 10-Years
24%
|
|
|
Yunnan Baiyao Group Co Ltd
SZSE:000538
|
Free Cash Flow
¥2.8B
|
CAGR 3-Years
0%
|
CAGR 5-Years
70%
|
CAGR 10-Years
11%
|
|
S
|
Sichuan Biokin Pharmaceutical Co Ltd
SSE:688506
|
Free Cash Flow
-¥697.3m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is Aurisco Pharmaceutical Co Ltd's Free Cash Flow?
Free Cash Flow
80.1m
CNY
Based on the financial report for Dec 31, 2023, Aurisco Pharmaceutical Co Ltd's Free Cash Flow amounts to 80.1m CNY.
What is Aurisco Pharmaceutical Co Ltd's Free Cash Flow growth rate?
Free Cash Flow CAGR 5Y
39%
The average annual Free Cash Flow growth rates for Aurisco Pharmaceutical Co Ltd have been 13% over the past three years , 39% over the past five years .
You don't have any saved screeners yet
